Cadila Healthcar - Press Release
02/10/2019 09:53
Cadila Healthcare Limited has informed the Exchange regarding a press release dated October 02, 2019, titled "Zydus announces positive results from EVIDENCES IV Phase 2 clinical trial of Saroglitazar Magnesium in NAFLD and NASH".